Evidence map›Paper›PMID 23423848›Full record

ArticleTransgenic research2013

False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models.

M D Lawrence, B J Blyth, R J Ormsby, W D Tilley, P J Sykes

Abstract read
PubMed Publisher
In one paragraph

Article in Transgenic research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M D LawrenceDepartment of Haematology and Genetic Pathology, Flinders Centre for Innovation in Cancer, Flinders University and Medical Centre, Flinders Drive, Bedford Park, Adelaide, South Australia, 5042, Australia.
B J Blyth
R J Ormsby
W D Tilley
P J Sykes

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TRAMP (Transgenic Adenocarcinoma of the Mouse Prostate) and LADY (Probasin-large T antigen transgenic mouse) mice are widely used autochthonous models of prostate cancer. Both models utilise probasin promoters to direct androgen-regulated expression of oncogenic SV40 specifically to epithelial cells of the mouse prostate. The oncogenic processes and phenotypes which result mimic many features of human prostate cancer, making these transgenic mouse models useful experimental systems. The terminal deoxynucleotidyl transferase (Tdt)-mediated dUTP in situ nick end labelling (TUNEL) assay is a commonly used method for the detection of cells undergoing apoptosis. In this study, we demonstrate false-positive TUNEL staining in frozen prostate tissue from TRAMP and LADY mice, which was not observed in non-transgenic control animals and is not due to non-specific binding of labelled-dUTP substrate. The false-positive signal co-localised with large SV40 T-antigen expression. False-positive signal was apparent using multiple commercial TUNEL kits with different detection systems. These results caution against the use of the TUNEL assay for detection of apoptosis in frozen prostate tissue of large T-antigen based autochthonous transgenic models of prostate cancer.

Indexed as

Disease Models, AnimalAndrogen-Binding ProteinAnimalsAntigens, Polyomavirus TransformingCaspase 3CryopreservationFalse Positive ReactionsFluorescenceHistonesImmunohistochemistryIn Situ Nick-End LabelingMaleMiceMice, TransgenicProstatic NeoplasmsReceptors, Tumor Necrosis Factor, Member 25Androgen-Binding ProteinAntigens, Polyomavirus TransformingCasp3 protein, mouseCaspase 3gamma-H2AX protein, mouseHistonesprobasinReceptors, Tumor Necrosis Factor, Member 25Tnfrsf25 protein, mouse

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.